Brought to you by 
Series A for Coherex brings in $8.5mm
29 Sep 2020
Executive Summary
Coherex Medical (developing technologies to treat heart defects) raised $8.5mm in a private placement of Series A convertible preferred shares led by Oxford Bioscience and vSpring Capital.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com